Trial
NCT05886491
A Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Takeda
Collaborators
—
Condition
Leukemia
Intervention
GDX012
Why stopped
Sponsor decision (No safety concern)
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-01